Amphastar Pharmaceuticals, Inc.

General ticker "AMPH" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $1.0B (TTM average)

Amphastar Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 0.5%.

Estimated limits based on current volatility of 2.3%: low 28.37$, high 29.71$

Factors to consider:

  • Total employees count: 1976 (-2.6%) as of 2025
  • US accounted for 94.7% of revenue in the fiscal year ended 2025-12-31
  • Top business risk factors: Dependence on key products, Supply chain disruptions, Regulatory and compliance, Market competition, Labor/talent shortage/retention
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [22.49$, 33.62$]
  • 2026-12-31 to 2027-12-31 estimated range: [23.99$, 35.55$]

Financial Metrics affecting the AMPH estimates:

  • Positive: with PPE of 8.3 at the end of fiscal year the price was neutral
  • Positive: 15.73 < Operating profit margin, % of 19.50
  • Positive: 11.28 < Operating cash flow per share per price, % of 12.42
  • Positive: 4.89 < Return on assets ratio (scaled to [-100,100]) of 5.68
  • Negative: Industry operating cash flow per share per price (median), % of -0.61 <= 0.01
  • Positive: Inventory ratio change, % of 2.37 <= 4.15

Similar symbols

Short-term AMPH quotes

Long-term AMPH plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $644.39MM $731.97MM $719.89MM
Operating Expenses $447.41MM $526.55MM $579.48MM
Operating Income $196.99MM $205.42MM $140.40MM
Non-Operating Income $-25.63MM $-15.65MM $-16.78MM
Interest Expense $27.16MM $30.34MM $25.48MM
R&D Expense $73.74MM $73.91MM $85.84MM
Income(Loss) $171.36MM $189.76MM $123.62MM
Taxes $31.83MM $29.67MM $25.53MM
Other Income(Loss) $-1.98MM $-0.57MM $0.00MM
Net Income(Loss)* $137.54MM $159.52MM $98.09MM
Stockholders Equity $639.42MM $732.30MM $788.80MM
Inventory $105.83MM $153.74MM $176.89MM
Assets $1,512.91MM $1,577.47MM $1,629.30MM
Operating Cash Flow $183.50MM $213.39MM $156.12MM
Capital expenditure $38.17MM $41.04MM $34.88MM
Investing Cash Flow $-649.12MM $-124.93MM $-70.33MM
Financing Cash Flow $454.09MM $-80.95MM $-67.42MM
Earnings Per Share** $2.85 $3.29 $2.10

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.